as per annexure enclosed
Awaiting price reaction for this filing.
Apollo Hospitals' board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2025. Standalone revenue rose to Rs. 820.2 crore for the quarter and Rs. 82,021 million for the year (vs Rs. 72,738 million last year), with profit after tax up ~28% to Rs. 12,963 million and EPS of Rs. 90.15. Consolidated revenue grew to Rs. 217,940 million (vs Rs. 190,592 million), with consolidated PAT jumping ~61% to Rs. 15,051 million and EPS of Rs. 100.56. The board recommended a final dividend of Rs. 10/share (200%), taking total FY25 dividend to Rs. 19/share (380%), amounting to ~Rs. 273 crore. The board also approved re-appointment of executive directors Preetha Reddy, Suneeta Reddy and Sangita Reddy, re-appointment of independent director Som Mittal, and a Rs. 285 crore acquisition of an existing 200-bed hospital. Credit ratings were reaffirmed at AA+/Stable by both CRISIL and India Ratings. Statutory auditors Deloitte Haskins & Sells LLP issued an unmodified opinion.
Strong consolidated earnings growth of ~61% YoY signals robust operational performance, especially in healthcare services and digital health segments, and should be viewed positively by shareholders. The healthy 380% total dividend payout reinforces income appeal, while the Rs. 285 crore hospital acquisition and unchanged AA+ rating support continued expansion without credit concerns.